ArticleCancers2024

Real-World Efficacy and Adherence to Palbociclib in HR-Positive, HER2-Negative Advanced Breast Cancer: Insights from a Romanian Cohort.

Cristian Virgil Lungulescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.